Xconomy National

Archives

by in
Entry Author Date Location
Seattle Genetics Sees Updated Side Effect Warning in Drug Label Luke Timmerman 01/13/12 Seattle
Seattle Genetics Sees Case of PML, Causing Market Twitch Luke Timmerman 12/01/11 Seattle
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer Ryan McBride 02/25/11 Boston
Calistoga Rolls Out More Evidence For Blood Cancer Drug, Sizes Up Pivotal Trial Luke Timmerman 12/05/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s Luke Timmerman 12/05/10 Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch Luke Timmerman 11/18/10 Seattle
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared Luke Timmerman 11/17/10 San Francisco
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News Erin Kutz 11/05/10 Boston
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology Luke Timmerman 11/03/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News Erin Kutz 10/22/10 Boston
Biogen, Genentech Revamp Alliance Luke Timmerman 10/21/10 San Francisco
Calistoga Starts Mid-Stage Trial Luke Timmerman 10/19/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer Luke Timmerman 09/27/10 Seattle
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader Luke Timmerman 08/17/10 San Francisco
Novartis Test Drives Biotech Startup Adimab’s Drug Discovery Engine Ryan McBride 07/09/10 Boston
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug Luke Timmerman 06/14/10 San Francisco
Calistoga Pharmaceuticals Builds Stronger Case for Blood Cancer Drug Luke Timmerman 06/07/10 Seattle
Trubion Wins Genentech, Biogen Patent Case Luke Timmerman 06/03/10 Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug Luke Timmerman 05/26/10 Seattle
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer Luke Timmerman 04/29/10 Seattle
Dendreon Hires Roche Sales Boss Luke Timmerman 04/08/10 Seattle
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug Luke Timmerman 03/22/10 Seattle
Roche, Biogen Halt Arthritis Study Luke Timmerman 03/08/10 Boston
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO Luke Timmerman 01/07/10 Boston
Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal With Pfizer Luke Timmerman 12/17/09 Boston
Roche Scraps Partnership With Seattle Genetics on Lymphoma Drug Luke Timmerman 12/11/09 Seattle
Dendreon Grasps for $400M, ZymoGenetics Cuts 52 Jobs, Calistoga Advances at ASH, & More Seattle-Area Life Sciences News Luke Timmerman 12/10/09 Seattle
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone Luke Timmerman 12/09/09 Boston
Seattle Genetics, Genentech Lymphoma Drug Passes Early Test with “Naked” Antibody Luke Timmerman 12/07/09 Seattle
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore Luke Timmerman 11/19/09 Boston
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.